PureTech Health (LON:PRTC) Trading Down 12.4% - Here's What Happened

PureTech Health plc (LON:PRTC - Get Free Report) shares were down 12.4% during trading on Thursday . The stock traded as low as GBX 100.40 ($1.32) and last traded at GBX 103 ($1.36). Approximately 3,018,245 shares traded hands during mid-day trading, an increase of 192% from the average daily volume of 1,035,028 shares. The stock had previously closed at GBX 117.60 ($1.55).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group restated a "buy" rating and set a GBX 455 ($6.00) price target on shares of PureTech Health in a research note on Monday, December 16th.

PureTech Health Stock Performance

The stock has a 50-day moving average price of GBX 134.79 and a 200-day moving average price of GBX 147.92. The firm has a market capitalization of £373.67 million, a PE ratio of -5.10 and a beta of 1.02. The company has a debt-to-equity ratio of 45.82, a current ratio of 3.68 and a quick ratio of 2.51.

PureTech Health Company Profile

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.